Copyright
©The Author(s) 2018.
World J Gastroenterol. Nov 7, 2018; 24(41): 4617-4621
Published online Nov 7, 2018. doi: 10.3748/wjg.v24.i41.4617
Published online Nov 7, 2018. doi: 10.3748/wjg.v24.i41.4617
Figure 1 Direct and indirect factors considered responsible for development of atherosclerosis and cardiovascular disease in chronic hepatitis C patients and the possible effect of hepatitis C virus clearance by direct-acting antiviral agents on cardiovascular outcomes.
DAAs: Direct-acting antiviral agents; IR: Insulin resistance; OXS: Oxidative stress; LPS: Lipopolysaccharide (endotoxinemia).
- Citation: Adinolfi LE, Rinaldi L, Nevola R. Chronic hepatitis C, atherosclerosis and cardiovascular disease: What impact of direct-acting antiviral treatments? World J Gastroenterol 2018; 24(41): 4617-4621
- URL: https://www.wjgnet.com/1007-9327/full/v24/i41/4617.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i41.4617